Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

investor.lilly.com

Eli Lilly and Company News Releases

Get the latest updates from Eli Lilly and Company News Releases directly as they happen.

Follow now 265 followers

Latest posts

Last updated about 11 hours ago

Lilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment

about 12 hours ago

Verzenio is the first contemporary therapy in over two decades to demonstrate...

Lilly confirms date and conference call for third-quarter 2025 financial results announcement

1 day ago

INDIANAPOLIS , Oct. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE...

WHO Foundation and Lilly Collaborate to Support Global Dementia Action Plan

5 days ago

Berlin, October 13, 2025 -- The WHO Foundation and Lilly have announced...

Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem

21 days ago

New 82,514 square foot facility will accommodate up to 15 biotech companies...

Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease

22 days ago

Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive...

U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer

22 days ago

An estimated 50% of patients with ER+, HER2 – metastatic breast cancer...

Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas

24 days ago

The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020...

Lilly's oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial

about 1 month ago

For the primary endpoint, orforglipron lowered A1C by 2.2% vs. 1.4% with...